Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMEKIZUMAB-BKZX for Psoriatic arthropathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,033 adverse event reports in the FDA FAERS database where BIMEKIZUMAB-BKZX was used for Psoriatic arthropathy.

Most Reported Side Effects for BIMEKIZUMAB-BKZX

Side Effect Reports % Deaths Hosp.
Product dose omission issue 694 13.0% 0 24
Psoriasis 621 11.6% 0 9
Drug ineffective 402 7.5% 0 11
Product availability issue 364 6.8% 0 17
Off label use 335 6.3% 3 39
Psoriatic arthropathy 301 5.6% 0 15
Injection site pain 263 4.9% 0 8
Therapy interrupted 252 4.7% 0 15
Hidradenitis 233 4.4% 0 14
Inappropriate schedule of product administration 214 4.0% 0 11
Incorrect dose administered 209 3.9% 0 5
Oral candidiasis 178 3.3% 0 9
Pain 159 3.0% 1 5
Fatigue 148 2.8% 0 6
Headache 146 2.7% 0 7

Other Indications for BIMEKIZUMAB-BKZX

Psoriasis (3,059) Product used for unknown indication (716) Hidradenitis (598) Ankylosing spondylitis (199) Off label use (199) Axial spondyloarthritis (55) Rheumatoid arthritis (39) Dermatitis atopic (31) Illness (21) Pustular psoriasis (20)

Other Drugs Used for Psoriatic arthropathy

ADALIMUMAB (47,183) ETANERCEPT (39,876) SECUKINUMAB (38,507) APREMILAST (33,990) CERTOLIZUMAB PEGOL (10,537) METHOTREXATE (6,997) RISANKIZUMAB-RZAA (6,970) TOFACITINIB (6,384) USTEKINUMAB (5,909) IXEKIZUMAB (5,798)

Related Pages

BIMEKIZUMAB-BKZX Full Profile All Psoriatic arthropathy Drugs BIMEKIZUMAB-BKZX Demographics BIMEKIZUMAB-BKZX Timeline